Literature DB >> 32447774

Cell surface IL-1α trafficking is specifically inhibited by interferon-γ, and associates with the membrane via IL-1R2 and GPI anchors.

Julie N E Chan1, Melanie Humphry1, Lauren Kitt1, Dominika Krzyzanska1, Kara J Filbey2, Martin R Bennett1, Murray C H Clarke1.   

Abstract

IL-1 is a powerful cytokine that drives inflammation and modulates adaptive immunity. Both IL-1α and IL-1β are translated as proforms that require cleavage for full cytokine activity and release, while IL-1α is reported to occur as an alternative plasma membrane-associated form on many cell types. However, the existence of cell surface IL-1α (csIL-1α) is contested, how IL-1α tethers to the membrane is unknown, and signaling pathways controlling trafficking are not specified. Using a robust and fully validated system, we show that macrophages present bona fide csIL-1α after ligation of TLRs. Pro-IL-1α tethers to the plasma membrane in part through IL-1R2 or via association with a glycosylphosphatidylinositol-anchored protein, and can be cleaved, activated, and released by proteases. csIL-1α requires de novo protein synthesis and its trafficking to the plasma membrane is exquisitely sensitive to inhibition by IFN-γ, independent of expression level. We also reveal how prior csIL-1α detection could occur through inadvertent cell permeabilisation, and that senescent cells do not drive the senescent-associated secretory phenotype via csIL-1α, but rather via soluble IL-1α. We believe these data are important for determining the local or systemic context in which IL-1α can contribute to disease and/or physiological processes.
© 2020 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  IL-1; Inflammation; Innate immunity; Interferon; Macrophage

Mesh:

Substances:

Year:  2020        PMID: 32447774     DOI: 10.1002/eji.201948521

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Alendronate Augments Lipid A-Induced IL-1α Release via Activation of ASC but Not Caspase-11.

Authors:  Riyoko Tamai; Izumi Mashima; Yusuke Kiyoura
Journal:  Inflammation       Date:  2021-06-02       Impact factor: 4.092

Review 2.  Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease.

Authors:  Katerina Pyrillou; Laura C Burzynski; Murray C H Clarke
Journal:  Front Immunol       Date:  2020-12-18       Impact factor: 7.561

3.  Nonredundancy of IL-1α and IL-1β is defined by distinct regulation of tissues orchestrating resistance versus tolerance to infection.

Authors:  Kevin Eislmayr; Annika Bestehorn; Luisa Morelli; Martina Borroni; Lieselotte Vande Walle; Mohamed Lamkanfi; Pavel Kovarik
Journal:  Sci Adv       Date:  2022-03-02       Impact factor: 14.136

Review 4.  Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease.

Authors:  Domenico Supino; Luna Minute; Andrea Mariancini; Federica Riva; Elena Magrini; Cecilia Garlanda
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.